Long-Term Neoplastic Risk Associated With Colorectal Strictures in Crohn's Disease: A Multicenter Study.

Cancer Colonic Stricture Crohn’s Disease

Journal

Gastro hep advances
ISSN: 2772-5723
Titre abrégé: Gastro Hep Adv
Pays: Netherlands
ID NLM: 9918350485906676

Informations de publication

Date de publication:
2024
Historique:
received: 05 01 2024
accepted: 07 05 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

While the occurrence of colonic stricture in Crohn's disease (CD) always raises concerns about the risk of cancer, the neoplastic risk associated with its stricture remains poorly known. All consecutive patients with colorectal stricture complicating CD in 3 academic centers between 1993 and 2022 were included in a retrospective cohort. We collected clinical, endoscopic, surgical, and pathology data and information on outcomes. Factors associated with neoplastic stricture were investigated by logistic regression. A total of 88 patients (median age, 25 [interquartile range {IQR}, 19-37] years and median disease duration 12 [4-19] years) with 96 colorectal strictures were included. Strictures were nonpassable by the scope in 61.4% (n = 54) of cases, 70.5% (n = 62) were ulcerated, and 62.5% (n = 55) were symptomatic. Colonic resection and endoscopic balloon dilatation were needed in 47.7% (n = 42) and 28.6% (n = 12) of patients, respectively. After a median follow-up of 21.5 months (IQR [5.5-46.5]), 7 (8%) patients were diagnosed with neoplasia at the colonic stricture site (colonic adenocarcinoma, n = 5; neuroendocrine carcinoma, n = 1; and B-cell lymphoproliferative neoplasia, n = 1), with a median stricture duration at colorectal neoplasia diagnosis of 0 month (IQR [0.0-5.5]). While neoplastic strictures were diagnosed in older patients (58 vs 39 years), with longer disease duration (18 vs 11 years) and frequent obstructive symptoms (57.1% vs 11.1%), no patient-related or stricture-related factor was associated with neoplastic stricture in multivariate analysis. Eight percent of patients with colonic stricture complicating CD developed colorectal cancer. Colorectal cancer and stricture were often diagnosed at the same time and we did not report malignant stricture after 1 year of follow-up.

Sections du résumé

Background and Aims UNASSIGNED
While the occurrence of colonic stricture in Crohn's disease (CD) always raises concerns about the risk of cancer, the neoplastic risk associated with its stricture remains poorly known.
Methods UNASSIGNED
All consecutive patients with colorectal stricture complicating CD in 3 academic centers between 1993 and 2022 were included in a retrospective cohort. We collected clinical, endoscopic, surgical, and pathology data and information on outcomes. Factors associated with neoplastic stricture were investigated by logistic regression.
Results UNASSIGNED
A total of 88 patients (median age, 25 [interquartile range {IQR}, 19-37] years and median disease duration 12 [4-19] years) with 96 colorectal strictures were included. Strictures were nonpassable by the scope in 61.4% (n = 54) of cases, 70.5% (n = 62) were ulcerated, and 62.5% (n = 55) were symptomatic. Colonic resection and endoscopic balloon dilatation were needed in 47.7% (n = 42) and 28.6% (n = 12) of patients, respectively. After a median follow-up of 21.5 months (IQR [5.5-46.5]), 7 (8%) patients were diagnosed with neoplasia at the colonic stricture site (colonic adenocarcinoma, n = 5; neuroendocrine carcinoma, n = 1; and B-cell lymphoproliferative neoplasia, n = 1), with a median stricture duration at colorectal neoplasia diagnosis of 0 month (IQR [0.0-5.5]). While neoplastic strictures were diagnosed in older patients (58 vs 39 years), with longer disease duration (18 vs 11 years) and frequent obstructive symptoms (57.1% vs 11.1%), no patient-related or stricture-related factor was associated with neoplastic stricture in multivariate analysis.
Conclusion UNASSIGNED
Eight percent of patients with colonic stricture complicating CD developed colorectal cancer. Colorectal cancer and stricture were often diagnosed at the same time and we did not report malignant stricture after 1 year of follow-up.

Identifiants

pubmed: 39280924
doi: 10.1016/j.gastha.2024.05.003
pii: S2772-5723(24)00069-4
pmc: PMC11401584
doi:

Types de publication

Journal Article

Langues

eng

Pagination

731-737

Informations de copyright

© 2024 The Authors.

Auteurs

Thomas Hunaut (T)

Department of Gastroenterology, Reims University Hospital, Université de Champagne-Ardenne, Reims, France.

Laurent Peyrin-Biroulet (L)

Department of Gastroenterology, Nancy University Hospital, Vandœuvre-lès-Nancy, France.
INFINY Institute, Nancy University Hospital, Vandœuvre-lès-Nancy, France.
FHU-CURE, Nancy University Hospital, Vandœuvre-lès-Nancy, France.
Groupe Hospitalier privé Ambroise Paré - Hartmann, Paris IBD Center, Neuilly sur Seine, France.
Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.

Antoine Le Bozec (A)

Department of Pharmacy, Reims University Hospital, Université de Champagne-Ardenne, Reims, France.

Adeline Germain (A)

Department of Digestive Surgery, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.

Corinne Gower-Rousseau (C)

Research and Public Health Unit, Reims University Hospital, Université de Champagne-Ardenne, Reims, France.

Charles Sabbagh (C)

Department of Digestive Surgery, CHU d'Amiens Picardie, Amiens Cedex 01, France.
UR UPJV 7518, SSPC (Simplification of Surgical Patients Care), Université de Picardie Jules Verne, Amiens, France.

Guillaume Cadiot (G)

Department of Gastroenterology, Reims University Hospital, Université de Champagne-Ardenne, Reims, France.

Mathurin Fumery (M)

Department of Gastroenterology, Amiens University Hospital, and PeriTox, Université de Picardie, Amiens, France.

Classifications MeSH